Novo Nordisk | NVO - Ordinary Share Capital



Novo Nordisk reported DKK446M in Ordinary Share Capital for its fiscal quarter ending in March of 2025.


Ordinary Share Capital Change Date
ANI Pharmaceuticals USD 2K 0 Mar/2025
Aurora Cannabis CAD 56.25M 6.92B Jun/2025
Bausch Health Companies USD 369.75M 10.14B Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Canopy Growth CAD 205.15M 8.47B Jun/2025
Corcept Therapeutics USD 105.29M 105.15M Jun/2025
Drreddys Laboratories INR 832.37M 1.63M Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
Merck USD 1.79B 0 Mar/2025
Novartis USD 793M 0 Dec/2024
Novo Nordisk 4.44B 3.99B Jun/2025
Novo Nordisk DKK 446M 0 Mar/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 6.56B Jun/2025
Prestige Brands USD 49.21M 48.65M Jun/2025
Sanofi 1.22B 36.5M Jun/2025
Supernus Pharmaceuticals USD 56.12M 130K Jun/2025
Zoetis USD 443.95M 438.95M Jun/2025